Scott Lassman is a partner in Goodwin’s Technology & Life Sciences group. Mr. Lassman’s practice focuses on providing life cycle support to biotechnology, pharmaceutical and medical technology companies at all stages of development. He has extensive experience counseling senior management on navigating the FDA’s complex administrative processes and structure, including its dispute resolution and Citizen Petition processes, and has successfully obtained preliminary and permanent injunctive relief from the FDA in drug and device cases. He routinely provides strategic advice on product approval and lifecycle management issues, including the Hatch-Waxman Act and biosimilars law, and also advises clients on corporate, licensing and intellectual property issues.

Previously a partner at Kleinfeld, Kaplan & Becker, Mr. Lassman joined Goodwin in 2016.

Areas of Practice
Domaines D’Expertise





Professional Experience

Mr. Lassman previously served as Senior Assistant General Counsel for the Pharmaceutical Research and Manufacturers of America (PhRMA), where he was responsible for FDA regulatory and policy matters. While at PhRMA, Mr. Lassman played a leading role in negotiating the Prescription Drug User Fee Act (PDUFA IV) with the FDA; enacting the Food and Drug Administration Amendments Act of 2007, and revising the PhRMA Code on Interactions with Healthcare Professionals.


Mr. Lassman has been recognized in Best Lawyers in America, Administrative and FDA Law (2010-2018), Who’s Who Legal: The International Who’s Who of Life Sciences Lawyers (2008, 2014, 2015, 2016), SuperLawyers (2013-2016) and LMG Life Science Stars — FDA Pharmaceutical and FDA Medical Devices. In 2007, he received the PhRMA Board of Directors Exceptional Service Award.

In The News









J.D., 1991
University of Virginia School of Law
(Order of the Coif)
M.A., 1988
University of Texas at Austin
B.A., 1985
Yale University
(cum laude)



District of Columbia
Get In Touch
German Translation
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique